Live feed
Filing
SC 13G
SC 13G0001193125-16-458701·Canaan IX L.P.
Schedule 13G ownership disclosure
CytomX Therapeutics Inc
Security class unavailable · CUSIP: 23284F105
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-16-458701
- Form type
- SC 13G
- Filer
- Canaan IX L.P.
- CIK
- CIK 1538676
- Filed
- Feb 11, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership